Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Evolus Inc (EOLS)

Evolus Inc (EOLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 604,520
  • Shares Outstanding, K 54,120
  • Annual Sales, $ 56,540 K
  • Annual Income, $ -163,010 K
  • 60-Month Beta 2.35
  • Price/Sales 10.92
  • Price/Cash Flow N/A
  • Price/Book 20.41
Trade EOLS with:

Options Overview

Details
  • Implied Volatility 91.60%
  • Historical Volatility 61.58%
  • IV Percentile 6%
  • IV Rank 6.00%
  • IV High 318.62% on 10/26/20
  • IV Low 77.10% on 07/06/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 30
  • Volume Avg (30-Day) 291
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 12,869
  • Open Int (30-Day) 17,396

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.25
  • Low Estimate -0.36
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +52.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.40 +4.81%
on 07/20/21
14.17 -23.08%
on 06/24/21
-3.06 (-21.92%)
since 06/23/21
3-Month
8.25 +32.12%
on 05/12/21
14.30 -23.78%
on 06/23/21
+1.73 (+18.87%)
since 04/23/21
52-Week
2.85 +282.46%
on 10/29/20
17.38 -37.28%
on 03/24/21
+7.56 (+226.35%)
since 07/23/20

Most Recent Stories

More News
Evolus to Report Second Quarter 2021 Results and Provide Business Update

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its second quarter 2021 financial...

EOLS : 10.90 (-2.42%)
Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations

Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that David K. Erickson has joined the company as...

EOLS : 10.90 (-2.42%)
Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau(R) in Patients with Skin of Color

Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced a peer reviewed journal article was published in...

EOLS : 10.90 (-2.42%)
Evolus Appoints Dan Stewart as Vice President and General Manager, International

Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced the appointment of Dan Stewart as Vice President...

EOLS : 10.90 (-2.42%)
Thinking about buying stock in Heron Therapeutics, Casper Sleep, Evolus, Xeris Pharmaceuticals, or Atara Biotherapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HRTX, CSPR, EOLS, XERS, and ATRA.

ATRA : 12.77 (-2.07%)
EOLS : 10.90 (-2.42%)
XERS : 3.36 (-4.55%)
HRTX : 12.89 (-1.15%)
CSPR : 7.03 (-1.13%)
Evolus Reports First Quarter 2021 Results and Provides Business Update

Q1 2021 Net Revenues of $12.2 million, Despite Half-Quarter ITC Impact

EOLS : 10.90 (-2.42%)
Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau(R) for the Treatment of Moderate to Severe Frown Lines

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced two newly published peer review studies in Aesthetic...

EOLS : 10.90 (-2.42%)
Aurora Cannabis (ACB) to Post Q3 Earnings: What's in Store?

Aurora Cannabis' (ACB) sturdy consumer cannabis sales are likely to have benefited its performance in the fiscal third quarter.

EYE : 52.83 (+1.81%)
EOLS : 10.90 (-2.42%)
ACB : 7.08 (-1.80%)
AMWL : 11.41 (-1.89%)
Schrodinger (SDGR) to Report Q1 Earnings: What's in Store?

Schrodinger's (SDGR) first-quarter results are likely to reflect benefits from collaborations.

EYE : 52.83 (+1.81%)
EOLS : 10.90 (-2.42%)
SDGR : 69.88 (-0.29%)
AMWL : 11.41 (-1.89%)
Why Evolus (EOLS) Might Surprise This Earnings Season

Evolus (EOLS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

EOLS : 10.90 (-2.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus,...

See More

Key Turning Points

3rd Resistance Point 11.98
2nd Resistance Point 11.73
1st Resistance Point 11.31
Last Price 10.90
1st Support Level 10.64
2nd Support Level 10.39
3rd Support Level 9.97

See More

52-Week High 17.38
Fibonacci 61.8% 11.83
Last Price 10.90
Fibonacci 50% 10.11
Fibonacci 38.2% 8.40
52-Week Low 2.85

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar